• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Sanarus Medical

edit

Sanarus Medical, Inc. develops and markets minimally invasive devices for the diagnosis and treatment of breast tumors. It offers Visica treatment system for cryoablation of breast fibroadenomas; Cassi II rotational core biopsy system, an automated hand held breast biopsy device to secure contiguous biopsy samples; and ImarC tissue marker system, a line of breast tissue markers that are visible under imaging modalities. The company was founded in 1999 and is headquartered in Pleasanton, California.

Recent Milestones

edit

• 
  Sanarus Medical received $15M in Series E funding. (2/20/07)
  Posted 9/15/09 at 7:25am via venturebeat.com
• 
  Sanarus Medical added Russell L.Delonzor as V.P., R&D. (12/1/02)
  Posted 5/1/13 at 12:45pm
• 
  Sanarus Medical added Robert C.Skidmore as Operations/Manufacturing Manager. (1/1/01)
  Posted 5/1/13 at 1:21pm
• 
  Sanarus Medical added Rodney E.Marcy as Vice President of Sales. (1/1/00)
  Posted 5/1/13 at 12:53pm
• 
  Sanarus Medical added Scott Long as Vice President of Sales and Vice President of New Business Development.
  Posted 4/25/13 at 1:21am

Videos

Screenshots

edit

Sources

1. Sanuras, breat tumor device company raises $15M (deals.venturebeat.com) [edit]